Lung adenocarcinoma promotion by air pollutants
2023 · Nature · 683 citations
https://doi.org/10.1038/s41586-023-05874-3
T
Takahiro Karasaki
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
175
Papers
3.9K
Citations
28
h-index
47
i10-index
Takahiro Karasaki is an academic researcher from The Francis Crick Institute. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics. The author has an h-index of 28, co-authored 149 publications.
ORCID: 0000-0001-6863-2360Papers by this author
worksTracking early lung cancer metastatic dissemination in TRACERx using ctDNA
2023 · Nature · 313 citations
https://doi.org/10.1038/s41586-023-05776-4
RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
2023 · Nature · 245 citations
https://doi.org/10.1038/s41586-023-05771-9
The evolution of non-small cell lung cancer metastases in TRACERx
2023 · Nature · 220 citations
https://doi.org/10.1038/s41586-023-05729-x
Genomic–transcriptomic evolution in lung cancer and metastasis
2023 · Nature · 188 citations
https://doi.org/10.1038/s41586-023-05706-4
Body composition and lung cancer-associated cachexia in TRACERx
2023 · Nature Medicine · 114 citations
https://doi.org/10.1038/s41591-023-02232-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat